Arachidonic acid
(ARA) was shown to possess safe and effective
schistosomicidal impact on larval and adult Schistosoma
mansoni and Schistosoma hematobium in vitro and in vivo in laboratory rodents and in children residing
in low and high endemicity regions. We herein examine mechanisms underlying
ARA schistosomicidal potential over two experiments, using in each
pool a minimum of 50 adult male, female, or mixed-sex freshly recovered,
ex vivo S. mansoni. Worms incubated
in fetal calf serum-free medium were exposed to 0 or 10 mM ARA for
1 h at 37 °C and immediately processed for preparation of surface
membrane and whole worm body homogenate extracts. Mixed-sex worms
were additionally used for evaluating the impact of ARA exposure on
the visualization of outer membrane cholesterol, sphingomyelin (SM),
and ceramide in immunofluorescence assays. Following assessment of
protein content, extracts of intact and ARA-treated worms were examined
and compared for SM content, neutral sphingomyelinase activity, reactive
oxygen species levels, and caspase 3/7 activity. Arachidonic acid
principally led to perturbation of the organization, integrity, and
SM content of the outer membrane of male and female worms and additionally
impacted female parasites via stimulating neutral sphingomyelinase
activity and oxidative stress. Arachidonic powerful action on female
worms combined with its previously documented ovocidal activities
supports its use as safe and effective therapy against schistosomiasis,
provided implementation of the sorely needed and long waited-for chemical
synthesis.